Finance

Lists
Why is VRAX down 5,69%?
Dive Deeper
VRAX:NASDAQ
Virax Biolabs Group Ltd
1,99 $
-5,69%
(-0,12) 1D
8 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRAX...
Open
2,13 $
High
2,13 $
Low
1,93 $
Mkt. cap
2,63 млн
Avg. vol.
149,66 м.
Volume
50,79 мың
52-wk high
21,75 $
52-wk low
1,83 $
EPS
-12,64 $
Beta
1,40
Shares outstanding
1,34 млн
No. of employees
26
Open
2,13 $
High
2,13 $
Low
1,93 $
Mkt. cap
2,63 млн
Avg. vol.
149,66 м.
Volume
50,79 мың
52-wk high
21,75 $
52-wk low
1,83 $
EPS
-12,64 $
Beta
1,40
Shares outstanding
1,34 млн
No. of employees
26
News stories
From web sources and news partners
About Virax Biolabs Group Ltd
CEO-
Employees26
Founded2013
HeadquartersЛондон, Англия, Ұлыбритания
SectorHealth care provider
Websiteviraxbiolabs.com
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
1,00 $
-49,7%
01/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
Revenue
804,00
804,00
5,41 мың
5,41 мың
Cost of goods sold
161,00
161,00
2,21 мың
2,21 мың
Cost of revenue
161,00
161,00
2,21 мың
2,21 мың
Research and development expenses
689,87 м.
689,87 м.
1,18 млн
1,18 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
603,51 м.
603,51 м.
731,02 м.
731,02 м.
Operating expense
1,29 млн
1,29 млн
1,91 млн
1,91 млн
Total operating expenses
1,29 млн
1,29 млн
1,91 млн
1,91 млн
Operating income
-1,29 млн
-1,29 млн
-1,91 млн
-1,91 млн
Other non operating income
-201,00
-201,00
218,00
218,00
EBT including unusual items
-1,31 млн
-1,31 млн
-1,66 млн
-1,66 млн
EBT excluding unusual items
-1,31 млн
-1,31 млн
-1,66 млн
-1,66 млн
Income tax expense
-136,80 м.
-136,80 м.
-313,32 м.
-313,32 м.
Effective tax rate
10,46%
10,46%
18,90%
18,90%
Other operating expenses
-
-
-
-
Net income
-1,17 млн
-1,17 млн
-1,34 млн
-1,34 млн
Net profit margin
-145 446,02%
-145 446,02%
-24 824,13%
-24 824,13%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-15,50 мың
-15,50 мың
-15,39 мың
-15,39 мың
Net interest expenses
-15,50 мың
-15,50 мың
-15,39 мың
-15,39 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,21 млн
-1,21 млн
-1,82 млн
-1,82 млн
Gain or loss from assets sale
213,00
213,00
15,88 мың
15,88 мың
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары